This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Burns Involving 40–49 Percent of Body Surface신체표면의 40-49%를 침범한 화상 (체표면적 40–49% 화상)

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: T31.4 (Burns involving 40-49% of body surface) | Special Copayment Reduction: V247 (Severe burn special copayment reduction: 5% copayment for 1 year from the registration date)
B. Synonyms40-49% TBSA burn, critical burn, critical major burn, burn of 40-49% of body surface area
C. Adult onsetWith damage to nearly half of the body's skin, long-term treatment in a burn intensive care unit and repeated reconstructive surgery are needed, and mortality rises sharply.
1. HistoryNearly fatal before the 1970s → survival 70~80% in modern specialized centers; contributions of skin substitutes and cell therapy
2. CausesLarge fires, explosions, industrial accidents, ignition of flammable clothing; inability to evacuate is the key risk factor
3. GeneticsSystemic cytokine response genes; insulin resistance genes; HLA and allograft skin rejection
4. General epidemiology5~8% of all burn admissions; mortality 15~25% in young adults; mortality rises sharply from 40% TBSA
5. PathophysiologySevere burn shock, SIRS, and CARS; delayed wound closure due to insufficient autologous donor sites; risk of recurrent sepsis
6. SymptomsShock, respiratory failure, severe pain, symptoms of multiple organ dysfunction; systemic metabolic derangement syndrome
7. SignsTachycardia, hypotension, oliguria, generalized edema; Revised Baux 70~90; ARDS, AKI, and liver dysfunction commonly accompany
8. ScreeningTBSA confirmation; Revised Baux; inhalation injury; SOFA score for multiorgan function; bacterial surveillance cultures
9. DiagnosisWhole-body burn map; confirmation of depth and TBSA; intensive ICU monitoring; staged surgical planning
10. TreatmentHigh-volume fluids; staged excision and grafting; essential use of allografts and artificial skin; intensive nutrition and critical care
11. PrognosisSurvival 70~80% in specialized centers; long hospitalization (2~4 months); chronic complications (scars, contractures, PTSD, muscle loss)
12. PreventionSprinklers and fire alarm systems; industrial fire prevention; burn transfer network; flame-resistant clothing
13. ReferencesPruitt BA et al. Management of burns in the resuscitative period … and 9 other papers

1. History

Burns reaching 40~49% TBSA have historically been regarded as the threshold of "fatal burns." Before the 1940s, survival in burns of 40% TBSA or more was below 10%, and most patients with burns of this size died within days to weeks after the burn from infection, dehydration, or organ failure. Experience treating burn patients in World War II and the Korean War clinically confirmed the importance of fluid resuscitation, which became the basis of modern burn resuscitation protocols.

In the 1960s~70s, as the Parkland formula was established, silver sulfadiazine was developed, and early eschar excision was adopted in succession, mortality in burns of 40% TBSA or more fell sharply. In particular, the cultured epithelial autograft (CEA) technique developed in 1979 by Janine Burke and Howard Green provided an innovative method of expanding graftable skin in large-area burns with insufficient autologous donor sites. With this technique, survival became possible even in burns of 90% TBSA or more.

Since the 1990s, the widespread use of artificial dermis (Integra Dermal Regeneration Template), bilayer artificial skin, and cadaveric allograft has become standard in the treatment of 40~49% TBSA burns. In the 2000s, negative pressure wound therapy (NPWT), recombinant growth factors (FGF, EGF), and stem cell technologies for skin regeneration began to be applied clinically, and in the 2020s skin fabrication using 3D bioprinting entered the clinical research stage. Survival of patients with 40~49% TBSA burns in specialized burn centers now reaches 70~80%, a dramatic improvement from below 10% half a century ago.


2. Causes

Critical burns of 40~49% TBSA are unlikely to result from simple household accidents and mostly occur in large-scale accidents. Large building fires are the most common cause, with extensive TBSA burns occurring particularly when escape routes are blocked (nursing homes, high-rise buildings, windowless rooms). Ignition or explosion during use of flammable liquids (gasoline, diesel, alcohol) causes whole-body flame burns in an instant, and in particular, when fuel leakage and ignition combine after a vehicle accident, large-area burns occur across the entire upper body.

Industrial fires and explosions occur in chemical plants, refineries, mines, and smelting facilities, and workers may already sustain thermal injury to 40% or more of TBSA before they can evacuate. In ignition of flammable clothing, particularly in older adults and children, when clothing burns and escape is difficult, the upper and lower limbs and even the trunk are extensively injured. Synthetic fibers such as nylon and polyester melt when burning and stick to the skin, causing more severe injury. Risk factors include older adults living alone, people with alcoholism, accidents during nighttime sleep, and lack of safety equipment.


3. Genetics

An individual's genetic characteristics play an important role in survival and the development of complications in 40~49% TBSA burns. Among cytokine storm-related genes, patients with high-expression genotypes for IL-6, TNF-α, and IL-1β production have a stronger and more persistent systemic inflammatory response after burns and a higher incidence of multiple organ failure. In contrast, with high-expression genotypes for anti-inflammatory cytokines (IL-10, TGF-β), the inflammatory response subsides quickly, but excessive immunosuppression increases susceptibility to infection.

In burns of 40% TBSA or more, where donor sites are limited by repeated harvesting of autologous skin, allograft skin is used as a necessity. HLA genotype directly affects the speed of immune rejection of allograft skin, and the greater the HLA mismatch, the faster rejection occurs, so that allograft skin sloughs within 2~4 weeks. Polymorphisms of the insulin receptor gene (INSR) and the glucose transporter gene (GLUT4) determine individual differences in post-burn insulin resistance, which affects how much intensive insulin therapy is needed. Polymorphisms of the beta-2 adrenergic receptor (ADRB2) gene, which affect the intensity of the hypermetabolic response, contribute to the severity of post-burn muscle protein breakdown and weight loss.


4. General epidemiology

Burns of 40~49% TBSA are relatively rare injuries accounting for about 5~8% of all burn admissions, of a severity that can be treated appropriately only in specialized burn centers. Worldwide, mortality in burns of 40% TBSA or more has declined steadily, improving from 40~50% in the 1980s to 15~25% today in specialized burn centers. In young adults (aged 20~40), mortality for 40~49% TBSA burns is about 15~25%, but at age 60 and over it rises greatly to 50~70% for the same TBSA.

By the Revised Baux Score, a 40-year-old patient with 40% TBSA has a score of 80, corresponding to a predicted mortality of about 15~20%. With inhalation injury, the score rises to 97 and the risk of death increases greatly. Statistically, from 40% TBSA onward, mortality tends to rise by about 10~15% for each 10% increase. The average hospital stay is 6~12 weeks, and an average of 4~8 skin graft-related operations are performed. Long-term rehabilitation of 1~3 years is needed after the burn, and permanent functional impairment and changes in appearance greatly affect quality of life.

In Korea, 7~10 specialized burn centers operate nationwide, and transfer to a specialized burn center is recommended for patients with severe burns of 40% TBSA or more regardless of distance. Establishment of a regional burn patient transfer system using helicopters is contributing to improved survival.


5. Pathophysiology

In 40~49% TBSA burns, the systemic pathophysiology is even more complex and severe. Without fluid resuscitation, burn shock can progress to hypovolemic cardiac arrest within hours. Because the amount of inflammatory mediators released from the extensive wounds is massive, the increase in systemic capillary permeability is very severe, and fluid volumes exceeding those calculated by the Parkland formula are frequently needed (fluid creep). Excess fluid leads to abdominal compartment syndrome, limb compartment syndrome, and pulmonary edema, further complicating treatment.

At 40% TBSA or more, an absolute shortage of autologous skin donor sites becomes a fundamental constraint on wound management. Donor skin for split-thickness grafts can be harvested only from unburned skin, and in a 40% TBSA burn the available donor skin is only 60% of the total, and even this must be supplemented through mesh grafting (1:4 or 1:6 expansion) and repeated harvesting (donor site cycling) to make up the shortfall. Because the risk of sepsis increases the longer wound closure is delayed, a strategy of first achieving temporary closure with allograft skin or artificial skin substitutes is important. As a pulmonary complication, ARDS due to the systemic inflammatory response can develop regardless of inhalation injury, and the period 2~5 days after the burn, when lung function deteriorates rapidly, is particularly dangerous.


6. Symptoms

Patients with 40~49% TBSA burns experience severe multisystem derangements. Symptoms of shock include extreme thirst, dizziness, a feeling of faintness, and decreased consciousness, and without treatment they progress to loss of consciousness and cardiac arrest within hours. Because the burn area is large, severe pain is distributed throughout the body, but deeply injured areas are painless, which can cause confusion in determining the extent of injury. As respiratory symptoms, dyspnea can develop 24~72 hours after the burn regardless of inhalation injury, and if it progresses to ARDS, hypoxia and respiratory failure worsen.

Systemic metabolic derangement causes extreme fatigue, chills, sweating, severe hunger, and thirst, and muscle wasting due to the hypermetabolic response progresses rapidly, causing marked loss of strength and weight within weeks. During long-term treatment, symptoms of multiple organ failure may appear in succession, such as recurrent high fever (sepsis), hypotension (septic shock), jaundice (liver dysfunction), oliguria (renal dysfunction), and bleeding tendency (DIC). Severe depression and lethargy due to prolonged hospitalization and severe psychological shock from changes in appearance are also prominent.


7. Signs

The clinical signs of 40~49% TBSA burns combine severe systemic instability with burn wound findings. Characteristic vital signs are tachycardia (>110~130/min), hypotension (systolic <90mmHg or a decrease of 30mmHg or more from normal), tachypnea (>24/min), and reduced urine output (<0.3mL/kg/hr). Severe generalized edema forms, peaking 48 hours after the burn and then gradually decreasing, but persistent edema is a problem in some patients. Mortality prediction with the Revised Baux Score is important for communication within the treatment team; a 45-year-old patient with 45% TBSA and no inhalation injury has a score of 90, corresponding to a predicted mortality of about 25~30%.

Blood tests show elevated hematocrit (plasma shift), hypoalbuminemia, hyponatremia, hyperkalemia, metabolic acidosis (decreased pH, increased lactate), thrombocytopenia (increased consumption), and prolonged PT/aPTT. Crackles or rhonchi on respiratory auscultation are early signs of ARDS or pneumonia.


8. Screening

In 40~49% TBSA burns, screening proceeds simultaneously with initial resuscitation. Accurate TBSA calculation and calculation of the Revised Baux Score must be done immediately, as they determine treatment intensity and the urgency of transfer to a burn center. Screening for inhalation injury is very important, and even without symptoms, bronchoscopic evaluation is performed if there are head and neck burns or a history of fire in an enclosed space. The SOFA score (Sequential Organ Failure Assessment) is calculated to quantify early signs of multiple organ dysfunction. Continuous hemodynamic monitoring is begun with immediate insertion of an arterial line, a central venous catheter, and an indwelling urinary catheter. Bacterial surveillance cultures of burn wounds are performed immediately after admission and 2~3 times a week thereafter.


9. Diagnosis

In creating the whole-body burn map, the depth and area of each region are recorded in detail on the Lund-Browder chart, and because the burn area is very large and initial assessment takes time, two or more burn specialists work together on the assessment. For burn depth classification, LDI is used at 48~72 hours to create a depth map of the entire wound area, on which the surgical plan is based. Staged surgical planning schedules operations considering the order of functional importance (face/hands/feet → trunk → lower limbs) and the order of infection risk. About 20~25% TBSA excised and grafted in one operation is the maximum limit, and the remainder is treated sequentially in subsequent operations.


10. Treatment

Parkland formula calculation for a 70kg patient with 45% TBSA: 4 × 70 × 45 = 12,600mL of fluid is given over the first 24 hours, with 6,300mL in the first 8 hours. During fluid resuscitation, maintaining urine output at 0.5~1mL/kg per hour is strictly observed to prevent "fluid creep" (excess fluid). For wound management, at 40% TBSA or more, cadaveric allograft is essential as a temporary cover because of insufficient autologous donor sites, and autologous donor sites are harvested repeatedly once they re-epithelialize. Artificial dermis (Integra) is used for dermal reconstruction in areas where full-thickness skin grafting is difficult. Cultured epidermal cells (CEA) can be considered when the shortage of donor sites is severe, but they have low durability and high cost. For intensive nutritional support, tube feeding is started within 6 hours after the burn, targeting protein 2.0~2.5g/kg/day, non-protein calories 35~45kcal/kg/day, and glutamine supplementation. Beta-blockers (propranolol) are widely used in treatment to attenuate the hypermetabolic response and lower heart rate.


11. Prognosis

The overall survival of patients with 40~49% TBSA burns treated in specialized burn centers is 70~80%, improving to 80~85% in young adults (aged 20~40). The main causes of death are sepsis and multiple organ failure (2~6 weeks after the burn), and with inhalation injury the risk of death increases by an additional 20~30%. The average hospital stay of survivors is 2~4 months, and 4~8 operations, including graft-related surgery, are needed. In the long-term prognosis, hypertrophic scars and contractures occur in 70~80% of survivors, requiring long-term treatment including reconstructive surgery. About 30~50% of survivors are able to return to work, requiring an average rehabilitation period of 18~24 months. The prevalence of PTSD reaches 30~50%.


12. Prevention

Because burns of 40% TBSA or more mostly occur in preventable large-scale accidents, structural prevention is key. Installing automatic sprinkler systems is the most effective means of preventing extensive burns in the first place by rapidly extinguishing fires in their early stages. In environments without automatically activated fire suppression systems, large-area burns are unavoidable when evacuation time is limited. Wearing flame-resistant clothing (FRC) delays ignition in the early stage of a fire, securing escape time and preventing spread of TBSA. Regular fire evacuation drills, building a burn transfer network (a hotline between specialized burn centers and primary care facilities), and education in burn severity triage improve the quality of initial treatment.


13. References

  1. Pruitt BA Jr, Goodwin CW, Mason AD Jr. Epidemiological, demographic, and outcome characteristics of burn injury. In: Herndon DN, ed. Total Burn Care. 4th ed. London: Saunders Elsevier; 2012:15-45.

  2. Osler T, Glance LG, Hosmer DW. Simplified estimates of the probability of death after burn injuries: extending and updating the Baux score. J Trauma. 2010;68(3):690-697. DOI: 10.1097/TA.0b013e3181c453b3. PMID: 20220427.

  3. Jeschke MG, van Baar ME, Choudhry MA, et al. Burn injury. Nat Rev Dis Primers. 2020;6(1):11. DOI: 10.1038/s41572-020-0145-5. PMID: 32054846.

  4. Alvarado R, Chung KK, Cancio LC, Wolf SE. Burn resuscitation. Burns. 2009;35(1):4-14. DOI: 10.1016/j.burns.2008.03.008. PMID: 18675523.

  5. Greenhalgh DG. Management of the skin and soft tissue of burn patients using biologic dressings: Part 2. J Burn Care Res. 2009;30(2):289-304. DOI: 10.1097/BCR.0b013e318198a910. PMID: 19261090.

  6. Muñoz N, Posthauer ME, Cereda E, Schols JM, Haesler E. The role of nutrition for pressure injury prevention and healing: the 2019 International Clinical Practice Guideline recommendations. Adv Skin Wound Care. 2020;33(3):123-136. DOI: 10.1097/01.ASW.0000653144.90739.ad. PMID: 32058438.

  7. Hart DW, Wolf SE, Mlcak R, et al. Persistence of muscle catabolism after severe burn. Surgery. 2000;128(2):312-319. DOI: 10.1067/msy.2000.108059. PMID: 10923011.

  8. Brusselaers N, Monstrey S, Vogelaers D, Hoste E, Blot S. Severe burn injury in Europe. Crit Care. 2010;14(5):R188. DOI: 10.1186/cc9300. PMID: 20958964.

  9. Sheridan RL, Tompkins RG. What's new in burns and metabolism. J Am Coll Surg. 2004;198(2):243-263. DOI: 10.1016/j.jamcollsurg.2003.09.027. PMID: 14759783.

  10. Orgill DP. Excision and skin grafting of thermal burns. N Engl J Med. 2009;360(9):893-901. DOI: 10.1056/NEJMct0804451. PMID: 19246361.